Article

Real-World medical expenses of Hematopoietic Stem Cell Transplantation in Japan: A Nationwide Database Study

2025-07-07

Abstract excerpt

<title>Abstract</title> <p>In Japan, medical expenses are primarily covered by a universal health insurance system, with data recorded in the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB), enabling a comprehensive analysis of nearly all inpatient and outpatient costs. To better understand the economic burden associated with hematopoietic stem cell transplantation (HSCT)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2af81367-4412-54da-bd9a-9b5c1faf4a44
DOI: 10.21203/rs.3.rs-6998815/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Real-World medical expenses of Hematopoietic Stem Cell Transplantation in Japan: A Nationwide Database StudyDOI 10.21203/rs.3.rs-6998815/v1Read

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort StudySemantic proximity Read

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I)Semantic proximity Read

Rare Disease Curative Care Expenditure- Financing Scheme-Health Provider- Beneficiary Group Analysis — An Empirical Study in Sichuan Province, ChinaSemantic proximity Read

Allogeneic Hematopoietic Cell Transplantation in the Outpatient SettingSemantic proximity Read

Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantationSemantic proximity Read

Medical Insurance Payment Schemes and Patient Medical Expenses: A Cross- Sectional Study of Lung Cancer Patients in Urban ChinaSemantic proximity Read

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databasesSemantic proximity Read

Financial Burden in Recipients of Allogeneic Hematopoietic Cell TransplantationSemantic proximity Read

Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseasesSemantic proximity Read

Healthcare resource utilization and costs during first salvage therapy for relapsed or refractory acute myeloid leukemia in the United States.Semantic proximity Read

Analysis of the Treatment Costs of Malignant Tumor Diseases in China’s Hunan Province Based on“System of Health Account 2011”Semantic proximity Read

Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician PerspectivesSemantic proximity Read